Sensitivity of magnetic resonance imaging in the detection of colorectal liver metastases

Annals of the Royal College of Surgeons of England

Volumn 90, Issue 1, 2008, Pages 25-28

  Blyth, S ^a   Blakeborough, A ^a   Peterson, M ^a   Cameron, I C ^a   Majeed, Ali W ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Hepatectomy; Histopathology; Liver metastases; MRI; Pre operative imaging; Ultrasonography

Indexed keywords

ADULT; AGED; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; ECHOGRAPHY; FALSE NEGATIVE RESULT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; INTRAOPERATIVE PERIOD; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PALPATION; PREOPERATIVE EVALUATION; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; STANDARD; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSTOPERATIVE CARE; PREOPERATIVE CARE; SENSITIVITY AND SPECIFICITY;

EID: 38949094510     PISSN: 00358843     EISSN: None     Source Type: Journal    
DOI: 10.1308/003588408X242303     Document Type: Article

References (14)

1. Scheele J, Altendorf-Hofmann A, Stangl R, Schmidt K. [Surgical resection of colorectal liver metastases: Gold standard for solitary and radically resectable lesions]. Swiss Surg 1996; Suppl 4: 4-17.
2. Hunt TM, Taylor I. The role of chemotherapy in the treatment and prophylaxis of colorectal liver metastases. Cancer Surv 1989: 8: 71-90.
3. Beard SM, Holmes M, Price C, Majeed AW. Hepatic resection for colorectal liver metastases: a cost-effectiveness analysis. Ann Surg 2000; 232: 763-76.
4. Gunven P, Makuuchi M, Takayasu K, Moriyama N, Yamasaki S, Hasegawa H. Preoperative imaging of liver metastases. Comparison of angiography, CT scan, and ultrasonography. Ann Surg 1985; 202: 573-9.
5. Miller DL, Simmons JT, Chang R, Ward BA, Shawker TH, Doppman JL et al. Hepatic metastasis detection: comparison of three CT contrast enhancement methods. Radiology 1987; 165: 785-90.
6. Soyer P, Levesque M, Elias O, Zeitoun G, Roche A. Detection of liver metastases from colorectal cancer: comparison of intraoperative US and CT during arterial portography. Radiology 1992; 183: 541-4.
7. Ward J, Naik KS, Guthrie JA, Wilson D, Robinson PJ. Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis. Radiology 1999; 210: 459-66.
8. Semelka RC, Shoenut JP, Ascher SM, Kroeker MA, Greenberg HM, Yaffe CS et al. Solitary hepatic metastasis: comparison of dynamic contrast-enhanced CT and MR imaging with fat-suppressed T2-weighted, breath-hold T1-weighted FLASH, and dynamic gadolinium-enhanced FLASH sequences. J Magn Reson Imaging 1994; 4: 319-23.
9. Hagspiel KD, Neidl KF, Eichenberger AC, Weder W, Marincek B. Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US. Radiology 1995; 196: 471-8.
10. Semelka RC, Cance WG, Marcos HB, Mauro MA. Liver metastases: comparison of current MR techniques and spiral CT during arterial portography for detection in 20 surgically staged cases. Radiology 1999; 213: 86-91.
11. Seneterre E, Taourel P, Bouvier Y, Pradel J, Van Beers B, Daures JP et al. Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology 1996; 200: 785-92.
12. Yang M, Martin DR, Karabulut N, Frick MP. Comparison of MR and PET imaging for the evaluation of liver metastases. J Magn Reson Imaging 2003; 17: 343-9.
13. Conlon R, Jacobs M, Dasgupta D, Lodge JP. The value of intraoperative ultrasound during hepatic resection compared with improved preoperative magnetic resonance imaging. Eur J Ultrasound 2003; 16: 211-6.
14. Jeffery GM, Hickey BE, Hider P. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database System Rev 2006; Issue 4.